content

Novel Method On Large DNA Sequences Insertion Successful

Recent work by researchers at Massachusetts General Hospital (MGH) in the US has improved the accuracy of inserting long DNA fragments into genomes. This method...

Pistoia Alliance Publishes Free Guide to Accelerate the Implementation of FAIR Principles in Clinical

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D launched its freely accessible FAIR4Clin guide. The guide...

BeiGene’s Brukinsa receives UK marketing authorisations to treat cancers

BeiGene, a global biotechnology company, announced that the U.S. FDAย  has approved its Brutonโ€™s tyrosine kinase inhibitor (BTKi) BRUKINSA (zanubrutinib) for the treatment of...

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that partner SK bioscience has received expanded...

K+N continues expansion of European pharma fleet

Why Kuehne+Nagel keeps investing in its European Pharma Fleet. If youโ€™re a regular user of European highways, you have likely shared the road with a...

EyePoint Pharmaceuticals to Build GMP Mfg. Facility in Northbridge, MA

EyePoint Pharmaceuticals, Inc., a company developing and commercializing therapeutics for serious eye disorders, has entered into a lease agreement to design and construct a...

CytoReason Licenses IBD Disease Model to Sanofi in Expanded Alliance

CytoReason, a pioneer in computational disease modeling, expanded its collaboration with Sanofi. The multiyear collaboration will further Sanofiโ€™s target discovery efforts via CytoReasonโ€™s AI...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read